{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:21:47Z","timestamp":1790266907330,"version":"4.1.0"},"reference-count":109,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Antimicrobial resistance (AMR) is a complex threat to human health and, to date, it represents a hot topic in drug discovery. The use of non-antibiotic molecules to block resistance mechanisms is a powerful alternative to the identification of new antibiotics. Bacterial efflux pumps exert the early step of AMR development, allowing the bacteria to grow in presence of sub-inhibitory drug concentration and develop more specific resistance mechanisms. Thus, efflux pump inhibitors (EPIs) offer a great opportunity to fight AMR, potentially restoring antibiotic activity. Based on our experience in designing and synthesizing novel EPIs, herein, we retrieved information around quinoline and indole derivatives reported in literature on this topic. Thus, our aim was to collect all data around these promising classes of EPIs in order to delineate a comprehensive structure\u2013activity relationship (SAR) around each core for different microbes. With this review article, we aim to help future research in the field in the discovery of new microbial EPIs with improved activity and a better safety profile.<\/jats:p>","DOI":"10.3390\/molecules26226996","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T21:00:50Z","timestamp":1637528450000},"page":"6996","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Microbial Efflux Pump Inhibitors: A Journey around Quinoline and Indole Derivatives"],"prefix":"10.3390","volume":"26","author":[{"given":"Giada","family":"Cernicchi","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo, 06123 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-8564","authenticated-orcid":false,"given":"Tommaso","family":"Felicetti","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo, 06123 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0971-3536","authenticated-orcid":false,"given":"Stefano","family":"Sabatini","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo, 06123 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2021). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2021, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41570-021-00313-1","article-title":"Towards the sustainable discovery and development of new antibiotics","volume":"5","author":"Miethke","year":"2021","journal-title":"Nat. Rev. Chem."},{"key":"ref_3","unstructured":"Kyriakides, S. (2021, November 16). EU Action on Antimicrobial Resistance|Public Health. Available online: https:\/\/ec.europa.eu\/health\/antimicrobial-resistance\/eu-action-on-antimicrobial-resistance.it."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/acsinfecdis.7b00071","article-title":"The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?","volume":"3","author":"Melander","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrd4675","article-title":"Antibiotic resistance breakers: Can repurposed drugs fill the antibiotic discovery void?","volume":"14","author":"Brown","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tim.2016.06.009","article-title":"Antibiotic Adjuvants: Rescuing Antibiotics from Resistance","volume":"24","author":"Wright","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijantimicag.2007.10.025","article-title":"Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: Mechanisms for their direct and indirect activities","volume":"31","author":"Martins","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3013","article-title":"Anti-virulence strategies to combat bacteria-mediated disease","volume":"9","author":"Rasko","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1038\/s41598-017-11892-9","article-title":"Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence","volume":"7","author":"Rampioni","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/acsinfecdis.7b00084","article-title":"Small-Molecule Potentiators for Conventional Antibiotics against Staphylococcus aureus","volume":"3","author":"Vermote","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1021\/acs.jmedchem.9b01279","article-title":"\u03b2-Lactamase Inhibitors to Restore the Efficacy of Antibiotics against Superbugs","volume":"63","author":"Pernas","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro1464","article-title":"Multidrug-resistance efflux pumps\u2014Not just for resistance","volume":"4","author":"Piddock","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41579-018-0048-6","article-title":"Multidrug efflux pumps: Structure, function and regulation","volume":"16","author":"Du","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/nar\/gkj001","article-title":"TCDB: The Transporter Classification Database for membrane transport protein analyses and information","volume":"34","author":"Saier","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.04.003","article-title":"Multidrug efflux pumps of Gram-positive bacteria","volume":"27","author":"Schindler","year":"2016","journal-title":"Drug Resist. Updates"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fmicb.2015.00377","article-title":"RND-type drug efflux pumps from Gram-negative bacteria: Molecular mechanism and inhibition","volume":"6","author":"Venter","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.bcp.2005.12.008","article-title":"Practical applications and feasibility of efflux pump inhibitors in the clinic\u2014A vision for applied use","volume":"71","author":"Lomovskaya","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1099\/mic.0.082412-0","article-title":"Understanding the basis of antibiotic resistance: A platform for drug discovery","volume":"160","author":"Piddock","year":"2014","journal-title":"Microbiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1128\/AAC.50.1.38-42.2006","article-title":"Ciprofloxacin-resistant Salmonella enterica serovar typhimurium strains are difficult to select in the absence of AcrB and TolC","volume":"50","author":"Ricci","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1126\/science.1208747","article-title":"Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments","volume":"333","author":"Zhang","year":"2011","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jac\/dkt420","article-title":"Inhibition of multidrug efflux as a strategy to prevent biofilm formation","volume":"69","author":"Baugh","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1128\/AEM.01310-08","article-title":"Inactivation of efflux pumps abolishes bacterial biofilm formation","volume":"74","author":"Kvist","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"37007","DOI":"10.1039\/C7RA03859C","article-title":"Investigation on the effect of known potent: S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation","volume":"7","author":"Sabatini","year":"2017","journal-title":"RSC Adv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1021\/acs.jmedchem.7b00215","article-title":"Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms","volume":"60","author":"Schillaci","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/med.21591","article-title":"Efflux pump inhibitors of clinically relevant multidrug resistant bacteria","volume":"39","author":"Lamut","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1574-6976.2008.00157.x","article-title":"Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems","volume":"33","author":"Martinez","year":"2009","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1128\/AAC.37.5.1086","article-title":"Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus","volume":"37","author":"Kaatz","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/infdis\/163.5.1080","article-title":"Mechanisms of Fluoroquinolone Resistance in Staphylococcus aureus","volume":"163","author":"Kaatz","year":"1991","journal-title":"J. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0042-6822(67)90105-5","article-title":"Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus","volume":"33","author":"Novick","year":"1967","journal-title":"Virology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0924-8579(02)00162-0","article-title":"The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus","volume":"20","author":"Price","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1128\/AAC.46.10.3133-3141.2002","article-title":"Multidrug Pump Inhibitors Uncover Remarkable Activity of Plant Antimicrobials","volume":"46","author":"Tegos","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1128\/AAC.39.12.2650","article-title":"Inducible NorA-Mediated Multidrug Resistance in Staphylococcus aureus","volume":"39","author":"Kaatz","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/jb.175.10.2888-2894.1993","article-title":"Overexpression of the MarA positive regulator is sufficient to confer multiple antibiotic resistance in Escherichia coli","volume":"175","author":"Gambino","year":"1993","journal-title":"J. Bacteriol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1099\/00221287-144-11-3003","article-title":"Porin alteration and active efflux: Two in vivo drug resistance strategies used by Enterobacter aerogenes","volume":"144","author":"Mallea","year":"1998","journal-title":"Microbiology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.bbrc.2005.01.069","article-title":"Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes","volume":"328","author":"Ghisalberti","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.46.8.2640-2643.2002","article-title":"The AcrAB\u2013TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes","volume":"46","author":"Pradel","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/jb.153.1.163-168.1983","article-title":"Transformation of intact yeast cells treated with alkali cations","volume":"153","author":"Ito","year":"1983","journal-title":"J. Bacteriol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1128\/AAC.49.8.3578-3582.2005","article-title":"Inducement and Reversal of Tetracycline Resistance in Escherichia coli K-12 and Expression of Proton Gradient-Dependent Multidrug Efflux Pump Genes","volume":"49","author":"Viveiros","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1271\/bbb.100433","article-title":"Evaluation and Target Validation of Indole Derivatives as Inhibitors of the AcrAB\u2013TolC Efflux Pump","volume":"74","author":"Zeng","year":"2010","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1006\/bbrc.2000.3159","article-title":"Membrane Permeability Modifications Are Involved in Antibiotic Resistance in Klebsiella pneumoniae","volume":"274","author":"Chevalier","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/j.1365-2958.1990.tb02040.x","article-title":"Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis","volume":"4","author":"Snapper","year":"1990","journal-title":"Mol. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JCM.44.3.783-789.2006","article-title":"Isolation of the genome sequence strain Mycobacterium avium 104 from multiple patients over a 17-year period","volume":"44","author":"Horan","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/acsinfecdis.5b00052","article-title":"Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium","volume":"1","author":"Machado","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1874285801307010059","article-title":"Multidrug Efflux Pumps in Staphylococcus aureus: An Update","volume":"7","author":"Costa","year":"2013","journal-title":"Open Microbiol. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12275-016-5159-z","article-title":"Multidrug efflux pumps in Staphylococcus aureus and their clinical implications","volume":"54","author":"Jang","year":"2016","journal-title":"J. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/AAC.33.9.1535","article-title":"Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus","volume":"33","author":"Ubukata","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.1128\/jb.172.12.6942-6949.1990","article-title":"Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones","volume":"172","author":"Yoshida","year":"1990","journal-title":"J. Bacteriol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.2147\/DDDT.S113556","article-title":"Homology modeling, molecular dynamics, and virtual screening of NorA efflux pump inhibitors of Staphylococcus aureus","volume":"10","author":"Bhaskar","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Tintino, S.R., de Souza, V.C.A., da Silva, J.M.A., Oliveira-Tintino, C.D., Pereira, P.S., Leal-Balbino, T.C., Pereira-Neves, A., Siqueira-Junior, J.P., da Costa, J.G.M., and Rodrigues, F.F.G. (2020). Effect of Vitamin K3 Inhibiting the Function of NorA Efflux Pump and Its Gene Expression on Staphylococcus aureus. Membranes, 10.","DOI":"10.3390\/membranes10060130"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Palazzotti, D., Bissaro, M., Bolcato, G., Astolfi, A., Felicetti, T., Sabatini, S., Sturlese, M., Cecchetti, V., Barreca, M.L., and Moro, S. (2019). Deciphering the Molecular Recognition Mechanism of Multidrug Resistance Staphylococcus aureus NorA Efflux Pump Using a Supervised Molecular Dynamics Approach. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20164041"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1128\/AAC.43.10.2404","article-title":"Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus","volume":"43","author":"Markham","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.37.1.128","article-title":"Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter","volume":"37","author":"Neyfakh","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1128\/jb.177.14.3904-3910.1995","article-title":"Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulated","volume":"177","author":"Ahmed","year":"1995","journal-title":"J. Bacteriol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bmc.2005.09.019","article-title":"Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors","volume":"14","author":"Samosorn","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1016\/j.bmc.2007.04.023","article-title":"Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus","volume":"15","author":"Marquez","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1016\/j.bmcl.2008.06.093","article-title":"Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus","volume":"18","author":"Ambrus","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/cmdc.201400042","article-title":"1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors","volume":"9","author":"Hequet","year":"2014","journal-title":"ChemMedChem"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1016\/j.bmc.2011.03.060","article-title":"Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents","volume":"19","author":"Burchak","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1016\/j.tetlet.2011.05.043","article-title":"Bromination of 3-substituted benzo[b]thiophenes: Access to Raloxifen intermediate","volume":"52","author":"Liger","year":"2011","journal-title":"Tetrahedron Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/cmdc.201500463","article-title":"C2 Arylated Benzo[b]thiophene Derivatives as Staphylococcus aureus NorA Efflux Pump Inhibitors","volume":"11","author":"Liger","year":"2016","journal-title":"ChemMedChem"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/acs.jmedchem.5b01219","article-title":"Indole Based Weapons to Fight Antibiotic Resistance: A Structure-Activity Relationship Study","volume":"59","author":"Lepri","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/ci600253e","article-title":"A Common Reference Framework for Analyzing\/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and Application","volume":"47","author":"Baroni","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1021\/jm400262a","article-title":"Re-evolution of the 2-phenylquinolines: Ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance","volume":"56","author":"Sabatini","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/acs.jmedchem.6b01281","article-title":"Improved Potency of Indole-Based NorA Efflux Pump Inhibitors: From Serendipity toward Rational Design and Development","volume":"60","author":"Buonerba","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2217\/fmb.13.16","article-title":"Inhibition of drug efflux pumps in Staphylococcus aureus: Current status of potentiating existing antibiotics","volume":"8","author":"Schindler","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1021\/jm200370y","article-title":"Evolution from a Natural Flavones Nucleus to Obtain 2-(4-Propoxyphenyl)quinoline Derivatives As Potent Inhibitors of the S. aureus NorA Efflux Pump","volume":"54","author":"Sabatini","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/i5020037","article-title":"Molecular Similarity of MDR Inhibitors","volume":"5","author":"Zloh","year":"2004","journal-title":"Int. J. Mol. Sci"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1021\/acs.jmedchem.8b00791","article-title":"2-Phenylquinoline S. aureus NorA efflux pump inhibitors: Evaluation of the importance of methoxy group introduction","volume":"61","author":"Felicetti","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejmech.2018.06.013","article-title":"Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position","volume":"155","author":"Felicetti","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/14756366.2020.1719083","article-title":"C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors","volume":"35","author":"Felicetti","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Cannalire, R., Mangiaterra, G., Felicetti, T., Astolfi, A., Cedraro, N., Massari, S., Manfroni, G., Tabarrini, O., Vaiasicca, S., and Barreca, M.L. (2020). Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197037"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1002\/cmdc.202100282","article-title":"From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search","volume":"16","author":"Cedraro","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/acs.jmedchem.6b01439","article-title":"Pharmacophore-based repositioning of approved drugs as novel Staphylococcus aureus NorA efflux pump inhibitors","volume":"60","author":"Astolfi","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"a000414","DOI":"10.1101\/cshperspect.a000414","article-title":"The Bacterial Cell Envelope","volume":"2","author":"Silhavy","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbapap.2008.11.005","article-title":"Outer Membrane Permeability and Antibiotic Resistance","volume":"1794","author":"Delcour","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z., Jubeh, B., and Karaman, R. (2020). Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It. Molecules, 25.","DOI":"10.3390\/molecules25061340"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nature01050","article-title":"Crystal structure of bacterial multidrug efflux transporter AcrB","volume":"419","author":"Murakami","year":"2002","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12300","article-title":"Structural basis for the inhibition of bacterial multidrug exporters","volume":"500","author":"Nakashima","year":"2013","journal-title":"Nature"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2217\/fmb.14.66","article-title":"Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance","volume":"9","author":"Blair","year":"2014","journal-title":"Future Microbiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/AAC.01866-13","article-title":"Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli","volume":"58","author":"Opperman","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1128\/AAC.03283-14","article-title":"Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors","volume":"58","author":"Vargiu","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.bmc.2015.03.016","article-title":"Structure\u2013activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors","volume":"23","author":"Nguyen","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2016.05.007","article-title":"Optimization of a novel series of pyranopyridine RND efflux pump inhibitors","volume":"33","author":"Aron","year":"2016","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1073\/pnas.1602472113","article-title":"Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives","volume":"113","author":"Sjuts","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fmicb.2015.00327","article-title":"Structural basis of RND-type multidrug exporters","volume":"6","author":"Yamaguchi","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1021\/jm010911z","article-title":"New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains","volume":"44","author":"Chevalier","year":"2001","journal-title":"J. Med. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1128\/AAC.41.10.2067","article-title":"Regulation of chromosomally mediated multiple antibiotic resistance: The mar regulon","volume":"41","author":"Alekshun","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jac\/dkm397","article-title":"MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli","volume":"61","author":"Keeney","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0924-8579(03)00215-2","article-title":"4-alkoxy and 4-thioalkoxyquinoline derivatives as chemosensitizers for the chloramphenicol-resistant clinical Enterobacter aerogenes 27 strain","volume":"22","author":"Gallo","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1042\/bj20030963","article-title":"Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates","volume":"376","author":"Mahamoud","year":"2003","journal-title":"Biochem. J."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Lamers, R.P., Cavallari, J.F., and Burrows, L.L. (2013). The Efflux Inhibitor Phenylalanine-Arginine Beta-Naphthylamide (PA\u03b2N) Permeabilizes the Outer Membrane of Gram-Negative Bacteria. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060666"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1128\/AAC.48.3.1043-1046.2004","article-title":"Inhibitors of Antibiotic Efflux in Resistant Enterobacter aerogenes and Klebsiella pneumoniae Strains","volume":"48","author":"Chevalier","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijantimicag.2006.03.010","article-title":"Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates","volume":"27","author":"Ghisalberti","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e3168","DOI":"10.7717\/peerj.3168","article-title":"Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli","volume":"5","author":"Machado","year":"2017","journal-title":"PeerJ"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/cmdc.202000359","article-title":"Spermine Derivatives of Indole-3-carboxylic Acid, Indole-3-acetic Acid and Indole-3-acrylic Acid as Gram-Negative Antibiotic Adjuvants","volume":"16","author":"Cadelis","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijantimicag.2015.01.012","article-title":"Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China","volume":"45","author":"Zhang","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Jones, M.M., Winthrop, K.L., Nelson, S.D., Duvall, S.L., Patterson, O.V., Nechodom, K.E., Findley, K.E., Radonovich, L.J., Samore, M.H., and Fennelly, K.P. (2018). Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197976"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1128\/AAC.05546-11","article-title":"The antibiotic resistance arrow of time: Efflux pump induction is a general first step in the evolution of mycobacterial drug resistance","volume":"56","author":"Schmalstieg","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijantimicag.2009.07.010","article-title":"The role of efflux pumps in macrolide resistance in Mycobacterium avium complex","volume":"34","author":"Rodrigues","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Rodrigues, L., Ramos, J., Couto, I., Amaral, L., and Viveiros, M. (2011). Ethidium bromide transport across Mycobacterium smegmatis cell-wall: Correlation with antibiotic resistance. BMC Microbiol., 11.","DOI":"10.1186\/1471-2180-11-35"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/jac\/dkn070","article-title":"Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis","volume":"61","author":"Rodrigues","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jac\/dkn178","article-title":"Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis","volume":"62","author":"Lechner","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Rindi, L. (2020). Efflux Pump Inhibitors against Nontuberculous Mycobacteria. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124191"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejmech.2017.09.014","article-title":"Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium","volume":"140","author":"Cannalire","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/acsinfecdis.9b00041","article-title":"Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants","volume":"5","author":"Felicetti","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1016\/j.bmc.2007.07.039","article-title":"MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: Highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate","volume":"15","author":"Yoshida","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e24905","DOI":"10.7554\/eLife.24905","article-title":"An allosteric transport mechanism for the AcrAB\u2013TolC multidrug efflux pump","volume":"6","author":"Wang","year":"2017","journal-title":"Elife"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1038\/s41467-020-18770-5","article-title":"Antibiotic export by MexB multidrug efflux transporter is allosterically controlled by a MexA-OprM chaperone-like complex","volume":"11","author":"Glavier","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/22\/6996\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:33:05Z","timestamp":1760167985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/22\/6996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":109,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["molecules26226996"],"URL":"https:\/\/doi.org\/10.3390\/molecules26226996","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]}}}